← Back to Search

Aerosol Box Use During Cardiopulmonary Resuscitation for Cardiac Arrest and Coronavirus Protection

N/A
Waitlist Available
Led By Adam C Cheng, MD
Research Sponsored by KidSIM Simulation Program
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
CPR Provider: Basic Life Support, Adult or Pediatric Advanced Life Support certification
Airway Provider: Adult or Pediatric Advanced Life Support certification
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after simulated resuscitation
Awards & highlights

Study Summary

This trial is researching how well an aerosol box protects HCWs from germs like the coronavirus when performing high-risk medical procedures.

Who is the study for?
This trial is for healthcare workers who perform CPR and other airway management procedures, such as doctors, nurses, respiratory therapists, and physician assistants. They must be certified in Advanced Life Support or Basic Life Support. Those unable to consent or with physical limitations that prevent task performance are excluded.Check my eligibility
What is being tested?
The study tests the effectiveness of an aerosol box designed to protect healthcare workers from airborne particles during CPR on patients with COVID-19. It aims to understand particle dispersion during these procedures and improve infection control measures.See study design
What are the potential side effects?
Since this trial involves a protective device rather than a medication, there are no direct side effects like those associated with drugs. However, potential indirect issues may include reduced accessibility or visibility while performing medical procedures.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am certified in Basic Life Support or Advanced Life Support.
Select...
I am certified in either Adult or Pediatric Advanced Life Support.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at 2, 4, 6, 8, and 10 minutes of simulated resuscitation.
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at 2, 4, 6, 8, and 10 minutes of simulated resuscitation. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of overall excellent CPR
Secondary outcome measures
Area of HCP contamination (cm2) for CPR providers
CC fraction
Disease particle concentration (ppm) at head of bed and over patient torso
+6 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Aerosol BoxExperimental Treatment1 Intervention
The team will complete the resuscitation scenario with an Aerosol box placed.
Group II: No Aerosol BoxActive Control1 Intervention
The team will complete the resuscitation scenario without an Aerosol box placed.

Find a Location

Who is running the clinical trial?

KidSIM Simulation ProgramLead Sponsor
8 Previous Clinical Trials
1,430 Total Patients Enrolled
2 Trials studying Cardiac Arrest
384 Patients Enrolled for Cardiac Arrest
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,341 Previous Clinical Trials
26,452,473 Total Patients Enrolled
6 Trials studying Cardiac Arrest
13,022 Patients Enrolled for Cardiac Arrest
Adam C Cheng, MDPrincipal InvestigatorUniversity of Calgary

Media Library

Aerosol Box Clinical Trial Eligibility Overview. Trial Name: NCT05868239 — N/A
Cardiac Arrest Clinical Trial 2023: Aerosol Box Highlights & Side Effects. Trial Name: NCT05868239 — N/A
Aerosol Box 2023 Treatment Timeline for Medical Study. Trial Name: NCT05868239 — N/A
Cardiac Arrest Research Study Groups: No Aerosol Box, Aerosol Box

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the participant range for this experiment restricted to individuals over twenty years of age?

"This clinical trial seeks out participants aged 18 to 60 years old."

Answered by AI

Who would be an ideal candidate for this research program?

"Eligible participants for this research endeavour must have suffered cardiac arrest and be between 18-60 years old. In total, 240 individuals are being sought out to participate in the study."

Answered by AI

How widespread is the execution of this trial in North America?

"This clinical trial is currently enlisting participants from 4 different sites. The cities of Calgary, Toronto and Montreal are amongst them as well as other nearby locations. To limit the need for travel during participation, it's wise to select a site that's closest to your home area."

Answered by AI

Are there still slots available for participants in this research endeavor?

"Clinicaltrials.gov confirms that this medical trial, initially posted on September 1st 2023, has concluded its recruitment period and is not seeking any more participants. Fortunately there are 854 other studies actively recruiting at the moment."

Answered by AI
~160 spots leftby Sep 2025